Skip to content

Clinical trials

Phase 2 Down Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Down Syndrome Phase: Phase 2 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20131
20142
20151
20181
20203
20211
20221
20234
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Terminated2
Withdrawn2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Colorado, Denver4
Eisai Inc.2
Hoffmann-La Roche2
Ohio State University2
University of Arizona2
Alnylam Pharmaceuticals1
Brigham and Women's Hospital1
Children's Hospital Medical Center, Cincinnati1
Icahn School of Medicine at Mount Sinai1
Jonathan Santoro1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Down Syndrome23
Sleep Apnea, Obstructive3
Alopecia Areata2
Autoimmune Diseases2
Dermatitis, Atopic2
Alzheimer Disease1
Autoimmune Diseases of the Nervous System1
Burkitt Lymphoma1
Catatonia1
Eczema1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.